- Home
- NKX vs EBS Comparison
NKX vs EBS Comparison
Compare NKX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKX | EBS |
|---|---|---|
| Founded | 2002 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.5M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | NKX | EBS |
|---|---|---|
| Price | $12.45 | $12.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 109.3K | ★ 848.8K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | ★ N/A | $8.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.78 | $4.02 |
| 52 Week High | $12.00 | $13.41 |
Technical Indicators
Market Signals| Indicator | NKX | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 26.51 | 64.02 |
| Support Level | $12.70 | $11.34 |
| Resistance Level | $12.80 | $12.28 |
| Average True Range (ATR) | 0.07 | 0.50 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 2.63 | 97.18 |
Price Performance
Historical ComparisonAbout NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.